Showing results (21-30 of 286) with videos related to
Sort By:
Pageof 29
Life Sciences|March 28, 2003
Troglitazone-binding to LDL and its glycated modifications: its role in cell-catalysed and Cu-mediated LDL-oxidationG Sobal, H Sinzinger, E J MenzelBiochemical Pharmacology|February 15, 2001
Calcium antagonists as inhibitors of in vitro low density lipoprotein oxidation and glycationG Sobal, E J Menzel, H SinzingerArzneimittel-Forschung|April 1, 1996
Intracellular distribution of ibuprofen within monocytesE J Menzel, M Binder, G KolarzInflammation|July 7, 1999
Inhibition of cytokine production and adhesion molecule expression by ibuprofen is without effect on transendothelial migration of monocytesE J Menzel, H Burtscher, G KolarzWiener Klinische Wochenschrift|December 23, 1983
[Interaction between fibronectin and aggregated IgG]E J Menzel, W Borth, B KaikBiofactors (Oxford, England)|January 1, 1997
The role of oxidative stress in the long-term glycation of LDLE J Menzel, G Sobal, A StaudingerGerontology|April 2, 1998
Comparison of normal and in vitro aging by non-enzymatic glycation as verified by differential scanning calorimetryR Reihsner, W Pfeiler, E J MenzelJournal of Receptor and Signal Transduction Research|March 11, 1999
Binding of long-term glycated low density lipoprotein and AGE-albumin by peripheral monocytes and endothelial cellsG Sobal, H Sinzinger, E J MenzelJournal of Cardiovascular Pharmacology|October 13, 2005
Troglitazone inhibits long-term glycation and oxidation of low-density lipoproteinGrazyna Sobal, E J Menzel, H SinzingerProstaglandins, Leukotrienes, and Essential Fatty Acids|July 6, 2000
The effects of glycation/glycoxidation on the liberation of 8-epi-PGF2alpha from low density lipoprotein during its in vitro oxidationG Sobal, E J Menzel, H SinzingerPageof 29